David Floyd

Board Director

Director

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 1 saleJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (5 ops.)

€188k

▼ Sales (5 ops.)

€12.1M

Latest filing published 03 Jun 2025 for Merit Medical Systems INC, €291k. Read the official filing

Filing timeline

BuySale

David Floyd

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

David Floyd: trading record in brief

Filings by David Floyd span 3 companies, the busiest being Stryker Corp, Merit Medical Systems Inc and NN Inc. In total, 66 filings cover trades dated from 20 January 2016 to 30 May 2025.

Market trades split into 5 purchases (€188k) and 5 sales (€12.1M). Sales outweigh purchases by €11.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 31 share grants and 19 option exercises. 2025 to date brings no purchases and 1 sale.

Half of the purchases are above €42k and half below. Across 5 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The newest entry dates from 3 June 2025: an open-market sale of €291k, in Merit Medical Systems Inc. The latest purchase dates back some time: it was published 2,266 days ago, on 6 August 2020. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.